

Stifel upgraded STAAR Surgical to Buy, while raising its price target, citing China momentum, EVO+ mix and upside to 2026-27 estimates.
You can purchase shares of Staar Surgical (NASDAQ:STAA) through any online brokerage.
Other companies in Staar Surgical’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).
Staar Surgical has a consensus price target of $28.20.
The stock price for Staar Surgical (NASDAQ: STAA) is $24.1 last updated October 28, 2026 at 7:23 AM EDT.
There are no upcoming dividends for Staar Surgical.
Staar Surgical does not have any upcoming earnings scheduled.
There is no upcoming split for Staar Surgical.
Staar Surgical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer...